Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) have earned an average rating of “Moderate Buy” from the sixteen ratings firms that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 12-month price target among […]
Wolff Wiese Magana LLC raised its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 2,680.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 139 shares of the medical instruments supplier’s stock after purchasing an additional 134 shares during the quarter. […]
/PRNewswire/ The global digital diabetes management market size is estimated to grow by USD 19.12 bn from 2024 to 2028, according to Technavio. The market.